These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9244566)

  • 21. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
    Andersson K; Bergström G; Petzold MG; Carlsten A
    Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electronic prescribing: a review of costs and benefits.
    Corley ST
    Top Health Inf Manage; 2003; 24(1):29-38. PubMed ID: 12674393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prescription of generic preparations].
    Ingerslev N
    Ugeskr Laeger; 1993 Jan; 155(4):253-4. PubMed ID: 8430476
    [No Abstract]   [Full Text] [Related]  

  • 26. Projected cost savings associated with cefmetazole: a new cephamycin for the hospitalized patient.
    Crane VS
    Hosp Formul; 1991 Apr; 26(4):302-6, 309-10. PubMed ID: 10109799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of prescription in discharge reports at a university hospital].
    Matoses Chirivella MC; Nájera Pérez MD; León Villar J; Iranzo Fernández MD; Plaza Aniorte J; Munilla Das A; Romero Crespo I; Ventura López M
    Farm Hosp; 2004; 28(3):180-7. PubMed ID: 15222871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study on rational drug prescribing and dispensing in outpatients in a tertiary care teaching hospital of Western Nepal.
    Alam K; Mishra P; Prabhu M; Shankar PR; Palaian S; Bhandari RB; Bista D
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):436-43. PubMed ID: 18603950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generic pharmaceutical prices continue their decline in prices from last year.
    Hosp Mater Manage; 1996 Feb; 21(2):1, 12-3. PubMed ID: 10154299
    [No Abstract]   [Full Text] [Related]  

  • 30. Do drug formulary policies reflect evidence of value?
    Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
    Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generic drugs in cardiology: will they reduce health care costs?
    Pitt B
    J Am Coll Cardiol; 2004 Jul; 44(1):10-3. PubMed ID: 15234397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic.
    Jones RA; Lopez LM; Beall DG
    Hosp Pharm; 1991 Sep; 26(9):778-82. PubMed ID: 10114011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
    Zachry WM; Doan QD; Clewell JD; Smith BJ
    Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M; Seal B; Pollack M; Wertz D
    Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulary conversion from glipizide to glyburide: a cost-minimization analysis.
    Nadel HL
    Hosp Pharm; 1995 Jun; 30(6):467-9, 472-4. PubMed ID: 10142848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of generic reference pricing interventions in the statin market.
    Puig-Junoy J
    Health Policy; 2007 Nov; 84(1):14-29. PubMed ID: 17368619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of generic-only drug coverage in a Medicare HMO.
    Christian-Herman J; Emons M; George D
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-455-68. PubMed ID: 15471765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.